Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
May 12, 16:00
Avadel Pharmaceuticals Enterprise Value : 2.070B for May 12, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Jazz Pharmaceuticals Plc | 16.84B |
| Perrigo Co. Plc | 4.987B |
| ANI Pharmaceuticals, Inc. | 2.095B |
| Lexicon Pharmaceuticals, Inc. | 957.57M |
| Medtronic Plc | 118.53B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.02M |
| Revenue (Quarterly) | 77.47M |
| Total Expenses (Quarterly) | 77.45M |
| EPS Diluted (Quarterly) | 0.0002 |
| Profit Margin (Quarterly) | 0.03% |
| Earnings Yield | -0.03% |
| Operating Earnings Yield | 0.21% |
| Normalized Earnings Yield | -0.0254 |